HIV infection and the intestinal mucosal barrier

Annals of the New York Academy of Sciences

Volumn 1258, Issue 1, 2012, Pages 19-24

  Epple, Hans Jörg ^a   Zeitz, Martin ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

HIV infection; Microbial translocation; Mucosal barrier; Tight junctions; Transepithelial resistance

Indexed keywords

VIRUS PROTEIN;

APOPTOSIS; ARTICLE; CYTOTOXIC T LYMPHOCYTE; EPITHELIUM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTESTINE MUCOSA; NONHUMAN; TIGHT JUNCTION; VIRUS REPLICATION;

EID: 84862894334     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2012.06512.x     Document Type: Article

References (55)

1. + T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J. Virol. 77: 11708-11717.
2. + T cells. Nature 434: 1148-1152.
3. + T cells in multiple tissues during acute SIV infection. Nature 434: 1093-1097.
4. Mehandru, S. et al 2004. Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. J. Exp. Med. 200: 761-770.
5. + T cell depletion and viral replication in SIV infection. Science 280: 427-431.
6. + T lymphocytes in patients infected with human immunodeficiency virus type 1 is more pronounced in the duodenal mucosa than in the peripheral blood. Berlin Diarrhea/Wasting Syndrome Study Group. Gut 37: 524-529.
7. Zeitz, M. et al 1998. HIV/SIV enteropathy. Ann. N. Y. Acad. Sci. 859: 139-148.
8. Kewenig, S. et al 1999. Rapid mucosal CD4(+) T-cell depletion and enteropathy in simian immunodeficiency virus-infected rhesus macaques. Gastroenterology 116: 1115-1123.
9. Brenchley, J.M. et al 2006. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 12: 1365-1371.
10. Brenchley, J.M., D.A. Price & D. C. Douek 2006. HIV disease: fallout from a mucosal catastrophe? Nat. Immunol. 7: 235-239.
11. Sodora, D.L. & G. Silvestri 2010. HIV, mucosal tissues, and T helper 17 cells: where we come from, where we are, and where we go from here. Curr. Opin. HIV AIDS 5: 111-113.
12. Keating, J. et al 1995. Intestinal absorptive capacity, intestinal permeability and jejunal histology in HIV and their relation to diarrhoea. Gut 37: 623-629.
13. Lim, S.G., I.S. Menzies, C.A. Lee, et al 1993. Intestinal permeability and function in patients infected with human immunodeficiency virus. A comparison with coeliac disease. Scand. J. Gastroenterol. 28: 573-580.
14. Obinna, F.C. et al 1995. Comparative assessment of small intestinal and colonic permeability in HIV-infected homosexual men. AIDS 9: 1009-1016.
15. Ott, M., B. Lembcke, S. Staszewski, et al 1991. Intestinal permeability in patients with acquired immunodeficiency syndrome (AIDS). Klin. Wochenschr. 69: 715-721.
16. Ancuta, P. et al 2008. Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients. PLoS One 3: e2516.
17. Jiang, W. et al 2009. Plasma levels of bacterial DNA correlate with immune activation and the magnitude of immune restoration in persons with antiretroviral-treated HIV infection. J. Infect. Dis. 199: 1177-1185.
18. Klatt, N. R. et al 2010. Compromised gastrointestinal integrity in pigtail macaques is associated with increased microbial translocation, immune activation, and IL-17 production in the absence of SIV infection. Mucosal Immunol. 3: 387-398.
19. Marchetti, G. et al 2008. Microbial translocation is associated with sustained failure in CD4+ T-cell reconstitution in HIV-infected patients on long-term highly active antiretroviral therapy. AIDS 22: 2035-2038.
20. + subjects with <50copies/ml HIV-1 RNA. J. Clin. Virol. 46: 367-370.
21. Stockmann, M. et al 1998. Duodenal biopsies of HIV-infected patients with diarrhoea exhibit epithelial barrier defects but no active secretion. AIDS 12: 43-51.
22. Sankaran, S. et al 2008. Rapid onset of intestinal epithelial barrier dysfunction in primary human immunodeficiency virus infection is driven by an imbalance between immune response and mucosal repair and regeneration. J. Virol. 82: 538-545.
23. Epple, H. J. et al 2010. Acute HIV infection induces mucosal infiltration with CD4+ and CD8+ T cells, epithelial apoptosis, and a mucosal barrier defect. Gastroenterology 139: 1289-1300.
24. Kotler, D.P., H.P. Gaetz, M. Lange, et al 1984. Enteropathy associated with the acquired immunodeficiency syndrome. Ann. Intern. Med. 101: 421-428.
25. Ullrich, R. et al 1989. Small intestinal structure and function in patients infected with human immunodeficiency virus (HIV): evidence for HIV-induced enteropathy. Ann. Intern. Med. 111: 15-21.
26. Epple, H.J. et al 2009. Impairment of the intestinal barrier is evident in untreated but absent in suppressively treated HIV-infected patients. Gut 58: 220-227.
27. Li, Q. et al 2008. Simian immunodeficiency virus-induced intestinal cell apoptosis is the underlying mechanism of the regenerative enteropathy of early infection. J. Infect. Dis. 197: 420-429.
28. Schmitz, H. et al 2002. Supernatants of HIV-infected immune cells affect the barrier function of human HT-29/B6 intestinal epithelial cells. AIDS 16: 983-991.
29. Nazli, A. et al Exposure to HIV-1 directly impairs mucosal epithelial barrier integrity allowing microbial translocation. PLoS Pathog 6: e1000852.
30. Clayton, F., S. Kapetanovic & D.P. Kotler 2001. Enteric microtubule depolymerization in HIV infection: a possible cause of HIV-associated enteropathy. AIDS 15: 123-124.
31. Kotler, D.P., S. Reka & F. Clayton 1993. Intestinal mucosal inflammation associated with human immunodeficiency virus infection. Dig. Dis. Sci. 38: 1119-1127.
32. Reka, S., M.L. Garro & D.P. Kotler 1994. Variation in the expression of human immunodeficiency virus RNA and cytokine mRNA in rectal mucosa during the progression of infection. Lymphokine Cytokine Res. 13: 391-398.
33. Olsson, J. et al 2000. Human immunodeficiency virus type 1 infection is associated with significant mucosal inflammation characterized by increased expression of CCR5, CXCR4, and beta-chemokines. J. Infect. Dis. 182: 1625-1635.
34. McGowan, I. et al 2004. Increased HIV-1 mucosal replication is associated with generalized mucosal cytokine activation. J. Acquir. Immune Defic. Syndr. 37: 1228-1236.
35. Abel, K., D.M. Rocke, B. Chohan, et al 2005. Temporal and anatomic relationship between virus replication and cytokine gene expression after vaginal simian immunodeficiency virus infection. J. Virol. 79: 12164-12172.
36. Li, Q. et al 2009. Glycerol monolaurate prevents mucosal SIV transmission. Nature 458: 1034-1038.
37. Quigley, M.F. et al 2006. Perforin expression in the gastrointestinal mucosa is limited to acute simian immunodeficiency virus infection. J. Virol. 80: 3083-3087.
38. + T cells in GALT: implications for immune control of HIV-1 infection. J. Immunol. 173: 641-648.
39. Zeissig, S. et al 2004. Downregulation of epithelial apoptosis and barrier repair in active Crohn's disease by tumour necrosis factor alpha antibody treatment. Gut 53: 1295-1302.
40. + secretion in human distal colon driven by prostaglandin E2. Am. J. Physiol. 271: G669-G674.
41. Heller, F. et al 2005. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology 129: 550-564.
42. Grotjohann, I., H. Schmitz, M. Fromm & J.D. Schulzke 2000. Effect of TNF alpha and IFN gamma on epithelial barrier function in rat rectum in vitro. Ann. N. Y. Acad. Sci. 915: 282-286.
43. Delezay, O. et al 1997. Direct effect of type 1 human immunodeficiency virus (HIV-1) on intestinal epithelial cell differentiation: relationship to HIV-1 enteropathy. Virology 238: 231-242.
44. Nazli, A. et al 2011. Exposure to HIV-1 directly impairs mucosal epithelial barrier integrity allowing microbial translocation. PLoS Pathog 6: e1000852.
45. Clayton, F. et al 2001. Gp120-induced Bob/GPR15 activation: a possible cause of human immunodeficiency virus enteropathy. Am. J. Pathol. 159: 1933-1939.
46. Canani, R.B. et al 2003. Effects of HIV-1 Tat protein on ion secretion and on cell proliferation in human intestinal epithelial cells. Gastroenterology 124: 368-376.
47. Canani, R.B. et al 2006. Inhibitory effect of HIV-1 Tat protein on the sodium-D-glucose symporter of human intestinal epithelial cells. AIDS 20: 5-10.
48. Buccigrossi, V. et al 2011. The HIV-1 transactivator factor (tat) induces enterocyte apoptosis through a redox-mediated mechanism. PLoS One 6: e29436.
49. Guadalupe, M. et al 2006. Viral suppression and immune restoration in the gastrointestinal mucosa of human immunodeficiency virus type 1-infected patients initiating therapy during primary or chronic infection. J. Virol. 80: 8236-8247.
50. Mehandru, S. et al 2006. Lack of mucosal immune reconstitution during prolonged treatment of acute and early HIV-1 infection. PLoS Med. 3: e484.
51. Estes, J. et al 2008. Collagen deposition limits immune reconstitution in the gut. J. Infect. Dis. 198: 456-464.
52. Sheth, P.M. et al 2008. Immune reconstitution in the sigmoid colon after long-term HIV therapy. Mucosal Immunol. 1: 382-388.
53. + T-cell restoration in gut-associated lymphoid tissue of HIV-infected patients is associated with enhanced Th17 cells and polyfunctional HIV-specific T-cell responses. Mucosal Immunol. 1: 475-488.
54. Schulbin, H. et al 2008. Cytokine expression in the colonic mucosa of HIV-infected individuals before and during nine months of antiretroviral therapy. Antimicrob. Agents Chemother. 52: 3377-3384.
55. + cell count. AIDS 25: 1385-1394.